Video Experimental Relacionado
Updated: Jul 23, 2026
10:43
Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
Inhibición de la metilación del ADN por agentes químicos carcinógenos in vitro
Cell
|January 1, 1983
Resumen
Los carcinógenos químicos interrumpen la metilación del ADN al inhibir la metiltransferasa del bazo del ratón y dañar directamente la enzima. Esto puede conducir a cambios hereditarios en los patrones de 5-metilcitosina en las células.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Toxicología Toxicología.
Sus antecedentes:
- La metilación del ADN es crucial para la regulación génica y el mantenimiento de la estabilidad genómica.
- Los carcinógenos químicos pueden interferir con los procesos celulares, lo que puede conducir a daños en el ADN y mutaciones.
Objetivo del estudio:
- Investigar los mecanismos por los cuales los carcinógenos químicos afectan la metilación del ADN.
- Determinar el impacto del daño del ADN inducido por carcinógenos en la actividad de la metiltransferasa y los patrones de metilación del ADN.
Principales métodos:
- Evaluación de la inhibición de la actividad de la metiltransferasa del bazo de ratón por varios agentes químicos cancerígenos.
- Evaluar la sensibilidad de la reacción de metilación a las lesiones del ADN como los dímeros de timina y las rupturas de doble hebra.
- Medición del contenido de 5-metilcitosina en el ADN después del tratamiento de carcinógenos en líneas celulares.
Principales resultados:
- Los carcinógenos químicos inhibieron significativamente la actividad de la metiltransferasa del ADN.
- Si bien los sitios alcalino-lables redujeron la capacidad del ADN para aceptar grupos metilo, la reacción fue menos sensible a los dímeros de timina o a las rupturas de doble cadena.
- Los carcinógenos indujeron lesiones alcalinas en el ADN y inactivaron directamente la enzima metiltransferasa.
- El tratamiento con benzo (a) pireno disminuyó el contenido de 5-metilcitosina en tipos celulares específicos.
Conclusiones:
- Los carcinógenos químicos afectan la metilación del ADN a través de múltiples vías, incluida la inhibición directa de la enzima y el daño al ADN.
- Estas alteraciones pueden conducir a alteraciones en los patrones de 5-metilcitosina, contribuyendo potencialmente a cambios hereditarios y a la carcinogénesis.
Más Videos Relacionados
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
12:15Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
Published on: May 29, 2019
Videos de Conceptos Relacionados
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...